Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Paxman is a leading Swedish medical technology company specializing in innovative scalp cooling solutions. The technology helps cancer patients worldwide effectively reduce chemotherapy-induced hair loss. Paxman continues to set new global standards in oncology care and patient-focused treatment.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Paxman is scheduled to report its next quarterly earnings on 11/20/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Paxman last reported quarterly earnings on 8/21/2026 (Q2 2026). Earnings per share (EPS) came in at 0.10 SEK.
Paxman has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.